Cerebrovascular Accident Clinical Trials
2 recruiting trials for Cerebrovascular Accident. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Cerebrovascular Accident clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Alliance Equiphoria (1), Shirley Ryan AbilityLab (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Hippotherapy (other, 1 trial), followed by Conventional Neurorehabilitation, Indego Nomad® Powered Knee-Ankle-Foot Orthosis (P-KAFO) (Parker Hannifin Corp., Cleveland, OH).
Track Cerebrovascular Accident trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Neurorehabilitation Through Hippotherapy of a Brain Stroke
Cerebrovascular accident \[CVA\] (medical term for stroke) is a high burden worldwide disorder and the second leading cause of disability. As illustrated by the number of...
Nomad P-KAFO Study
The goal of this clinical trial is to evaluate the impact of using the Nomad powered KAFO in people who have had a musculoskeletal or neurological injury that has affected their...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Cerebrovascular Accident, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Cerebrovascular Accident, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Cerebrovascular Accident, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.